He is the first expert in China to study the production, biological utilization, safety and antioxidant effect of natural astaxanthin. It is the first in the world to successfully develop high-activity astaxanthin raw materials, transform its research results and export them to many countries in Europe and Southeast Asia. Through scientific and technological innovation, the commercial large-scale production of algae-derived astaxanthin in China has become a reality, which has initiated the industrial development of algae-derived astaxanthin in China and filled the domestic gap, and is known as the "father of astaxanthin in China".
At present, we are mainly committed to the development and application of astaxanthin in the fields of medicine, food and daily chemicals. A number of astaxanthin research projects led by researchers are not only the first in the world, but also won many national scientific and technological honors. He is currently the general manager of Jingzhou Natural Astaxanthin Co., Ltd. and Hubei Yashida Biotechnology Co., Ltd., and the chief research and development expert of Astor Astaxanthin.
1990, graduated from the First Military Medical University of Chinese People's Liberation Army, and later served as the chief physician of the Department of Nephrology of China People's Liberation Army 16 1 Hospital, and published 20 related medical papers; Nearly a thousand papers on the basic research and application of natural astaxanthin have been published and translated and compiled into books.
In 2003, he graduated from Wuhan University with a degree in executive master of business administration.
In 2004, we established the first specialized breeding base of Haematococcus pluvialis in Asia in cooperation with Hang Lung Group, a company listed in the US stock market, to produce natural astaxanthin, one of the five largest bases in the world.
20 10 successfully promoted astaxanthin to be listed as a new resource food in China in the process of developing astaxanthin soft capsules and applying for "police tactical unit". Astaxanthin has since officially entered the food, health care and daily chemical industries in China;
In 20 12, the first effective astaxanthin soft capsule health care product in China was successfully developed, and it was approved by the state as an astaxanthin health care product of "police mobile force";
The scientific and technological projects independently developed by 20 13-20 14 won three national utility model patents, which were successfully applied to microalgae breeding production and medical system.
Since 20 15, he has participated in many prospective clinical trials of astaxanthin in IgA nephropathy, food, exercise, cardiovascular and cerebrovascular diseases, made breakthrough research progress, and successfully published relevant literature.
In 2020, the first museum of algae-derived astaxanthin biotechnology in China was successfully established.
In 20021year, the latest Nobel Prize-winning gene scissors technology was used for the first time in the world to carry out "research and development and industrialization of microalgae high-density culture and astaxanthin high-efficiency accumulation technology", and breakthrough progress was made and put into production and application.
In 2022, he led the research on the anti-atherosclerosis mechanism of astaxanthin and won the national "opening list" and provincial scientific and technological honor.